Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
14001
PUT
FTC Solar
FTCI
$35.5M
| $204 | ﹤0.01% |
+30
| New | +$108 |
2024 Q3
0 quarters
|
|
14002
PUT
Satellogic
SATL
$881M
| $204 | ﹤0.01% |
+200
| New | +$211 |
2024 Q3
0 quarters
|
|
|
INCR
14003
PUT
Intercure
INCR
$81.3M
| $201 | ﹤0.01% |
20
-20
| -50% | -$210 |
2023 Q1
6 quarters
|
|
14004
PUT
Entera Bio
ENTX
$495M
| $190 | ﹤0.01% |
+100
| New | +$177 |
2024 Q3
0 quarters
|
|
|
COEPW
14005
DELISTED
Coeptis Therapeutics Warrants
COEPW
| $177 | ﹤0.01% |
11,783
+253
| +2% | +$5 |
2024 Q1
2 quarters
|
|
|
KPLTW
14006
DELISTED
Katapult Holdings Warrant
KPLTW
| $177 | ﹤0.01% |
+32,206
| New | +$312 |
2024 Q3
0 quarters
|
|
14007
New Horizon Aircraft Ltd
HOVRW
$10.8M
| $171 | ﹤0.01% |
13,927
-53
| -0.4% | -$1 |
2024 Q2
1 quarter
|
|
14008
CALL
Immunic
IMUX
$109M
| $165 | ﹤0.01% |
10
-460
| -98% | -$6.55K |
2020 Q3
16 quarters
|
|
|
TUYA
14009
PUT
Tuya Inc
TUYA
$1.04B
| $165 | ﹤0.01% |
+100
| New | +$153 |
2024 Q3
0 quarters
|
|
|
KLRS
14010
PUT
Kalaris Therapeutics
KLRS
$64.3M
| $162 | ﹤0.01% |
9
-126
| -93% | -$2.2K |
2022 Q3
8 quarters
|
|
|
CPTNW
14011
DELISTED
Cepton, Inc. Warrant
CPTNW
| $154 | ﹤0.01% |
11,993
-207,460
| -95% | -$2.1K |
2023 Q3
4 quarters
|
|
|
BIOR
14012
PUT
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $150 | ﹤0.01% |
30
-340
| -92% | -$2.21K |
2024 Q2
1 quarter
|
|
14013
PUT
System1
SST
$21.2M
| $112 | ﹤0.01% |
+10
| New | +$128 |
2024 Q3
0 quarters
|
|
|
ZEPP
14014
PUT
Zepp Health
ZEPP
$56M
| $109 | ﹤0.01% |
25
-75
| -75% | -$211 |
2023 Q1
6 quarters
|
|
|
LYRA
14015
PUT
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $103 | ﹤0.01% |
8
-4
| -33% | -$59 |
2022 Q4
7 quarters
|
|
|
KRON
14016
PUT
DELISTED
Kronos Bio
KRON
| $100 | ﹤0.01% |
+100
| New | +$111 |
2024 Q3
0 quarters
|
|
14017
PUT
Vista Gold
VGZ
$390M
| $78 | ﹤0.01% |
100
| – | – |
2024 Q2
1 quarter
|
|
14018
PUT
Retractable Technologies
RVP
$20.9M
| $77 | ﹤0.01% |
+100
| New | +$101 |
2024 Q3
0 quarters
|
|
14019
CALL
United States Antimony
UAMY
$597M
| $76 | ﹤0.01% |
+100
| New | +$50 |
2024 Q3
0 quarters
|
|
|
14020
PUT
United States Antimony
UAMY
$597M
| $76 | ﹤0.01% |
100
| – | – |
2021 Q1
14 quarters
|
|
14021
PUT
Vor Biopharma
VOR
$1.11B
| $70 | ﹤0.01% |
+5
| New | +$91 |
2024 Q3
0 quarters
|
|
14022
Lulu's Fashion Lounge
LVLU
$39.2M
| $69 | ﹤0.01% |
3
| – | – |
2024 Q2
1 quarter
|
|
14023
Xcel Energy
XEL
$44.6B
| $65 | ﹤0.01% |
1
-448,328
| -100% | -$26.6M |
2017 Q1
30 quarters
|
|
|
FNUC
14024
PUT
Frontier Nuclear and Minerals Inc
FNUC
$46M
| $63 | ﹤0.01% |
+15
| New | +$96 |
2024 Q3
0 quarters
|
|
14025
PUT
VolitionRx Ltd
VNRX
$7.06M
| $60 | ﹤0.01% |
5
-10
| -67% | -$129 |
2024 Q2
1 quarter
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.